Ricardo, Jose W.
Qiu, Yuqing
Lipner, Shari R.
Article History
Received: 17 November 2023
Revised: 17 November 2023
Accepted: 5 December 2023
First Online: 25 March 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, approved by the Institutional Review Board of Weill Cornell Medicine (record #: 1609017586, approval date 01/08/2021), and registered on ClinicalTrials.gov (NCT03991936). This work is not under consideration at any other journal and has not been previously presented.
: A written informed consent was obtained from all participants included in this study.
: All subjects gave consent for the publication of recognizable patient photographs or other identifiable material with the understanding that this information may be publicly available.
: Dr. Jose W. Ricardo and Ms. Yuqing Qiu have no conflicts of interest relevant to the content of the submission. Dr. Lipner has served as a consultant for Ortho-Dermatologics, Moberg Pharmaceuticals, and BelleTorus Corporation.